BioCentury

1:16 AM GMT, Sep 10, 2008
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Company News

Pfizer withdraws dalbavancin applications

Pfizer (NYSE:PFE) withdrew an NDA in the U.S. and an MAA in Europe for dalbavancin

Read the full 154 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.